- Website
- bicara.com
- Total Funding
- $273.0M
- Last Round
- $165.0M Series CDec 2023
- Rounds
- 2
About
Bicara Therapeutics is a clinical-stage biopharmaceutical company developing bifunctional therapies for solid tumors, combining targeted therapies with tumor-microenvironment modulators.
Summary
Bicara is a Biotech company based in United States. It has raised $273.0M in total across 2 rounds, most recently a $165.0M Series C round in Dec 2023. Investors include RA Capital Management, TPG (Growth/Rise) and Red Tree Venture Capital.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2024
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform